Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : RXSD Rexall Sundown -- Ignore unavailable to you. Want to Upgrade?

To: Adelantado who wrote (204)	12/9/1998 9:40:00 PM
From: Adelantado	Respond to of 327

Before I closed, I found an e-mail message that yet another firm filed a class-action suit against RXSD for the same reasons the other firms last November did. That makes 7 seperate actions as far as I know. The firm from South Florida probably took more time to prepare the complaint and file than the more northern firms because, after all, Florida lawyers are known to be more retired, don't get up early and don't work late and on week-ends. So, what's a couple of weeks, anyway. I suggest that RXSD hire a more northern firm to handle all of them. Perhaps the same answer to all the complaints can be served on all the class-action plaintiffs to save costs. Joe.

To: Adelantado who wrote (204)	12/9/1998 9:51:00 PM
From: brent gephart	Read Replies (1) \| Respond to of 327

The compound allude to and its ability to do what they say is very important. This could be a lot more important than just a supplement. If the research continues to show these results this compound will have a huge market. Their are a lot of diseases this can work for and the research is showing that it does work for many of them. Look at the list below, for just an idea of what this compound can be applied to, from the press release. ProteoTech, Inc. is a drug discovery company focused on therapeutics and diagnostics for human disease utilizing proteoglycan technologies. The ''amyloid diseases'' all involve the accumulation of specific proteoglycans believed to augment the amyloid process and inhibit the body's natural ability to remove unwanted ''amyloid deposits.'' Proteoglycans are synthesized by virtually all cells of the body and play significant roles in the pathogenesis of a number of human diseases, including Alzheimer's, Down's syndrome, cancer, arthritis, atherosclerosis, heart disease and AIDS. Visit the Company's web site at www.proteotech.com .